Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

30.31
Delayed Data
As of Jan 19
 -0.25 / -0.82%
Today’s Change
20.07
Today|||52-Week Range
34.06
-1.65%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close30.56
Today’s open30.56
Day’s range29.90 - 30.56
Volume119,058
Average volume (3 months)255,706
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+58.04%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio151.5
Price/Sales11.37
Price/Book8.20

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.02-0.07%
LOXOLoxo Oncology Inc-0.62-1.55%
XNCRXencor Inc-0.56-2.40%
EGRXEagle Pharmaceutical...-4.12-5.88%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs